Objective: The purpose of this study was to determine the effects of core neuromuscular training on pain, balance, and performance in women with patellofemoral pain syndrome (PFPS). Methods: This randomized single-blind trial was based on a convenience sample of 28 women with unilateral PFPS. All participants were assigned randomly to the intervention or control group with a block randomization method. The control group received routine physical therapy exercise for PFPS. The intervention group received core neuromuscular training in addition to routine physical therapy exercise. The outcome measures evaluated were pain intensity (Visual Analog Scale), function (Kujala patellofemoral questionnaire and step-down performance test), and balance (Y balance test). Results: In both groups the pain score was significantly lower after treatment (P = .001). The slope of this trend was greater in the intervention group. The Kujala and step-down scores improved significantly after treatment in both groups, although the improvements were greater in the intervention group. The Y balance score improved in all 3 directions after therapy in both groups (P b .05); improvement was significantly greater in the intervention group only in the posteromedial direction (P = .016). Conclusion: For the group of participants studied, a 4-week core neuromuscular training plus routine physiotherapy exercise was more effective than routine physiotherapy exercise alone for improving pain, balance, and functional performance in individuals with PFPS.
The combined PRT-medical therapy is more effective than the medical therapy alone. Thus, the combination of PRT and medical therapy is suggested as a treatment choice for patients with migraine headache.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.